Search results
1 maj 2021 · Diabetic-ESRD patients have advanced atherosclerosis leading to the worst access survival rates; this often require a more proximal arteriovenous (AV) fistulas anastomosis, an insufficient blood flow rate of AV fistulas, higher rates of steal syndrome, and a greater premature failure rate of arteriovenous fistulas [109, 110].
The various and opposing effects of ESRD and dialysis can make blood glucose levels fluctuate widely, placing patients at risk of hypoglycemia—and presenting a challenge for nephrologists and internists. In this review, we summarize the available evidence and make practical recommenda-tions for managing diabetes in patients on he-modialysis.
5 paź 2021 · This review seeks to summarise the literature and tackle the intricacies of glycaemic management in patients with CKD who are either on maintenance haemodialysis or have received a kidney transplant.
31 paź 2022 · Salivary flow is significantly reduced in haemodialysis patients as a consequence of atrophy and fibrosis of the salivary glands [70]. Thirst in haemodialysis patients is also linked to both sodium and glucose levels, which is particularly relevant to diabetic patients on haemodialysis.
Regarding the accuracy of FGM in hemodialysis patients, Yajima et al. studied 13 uremic patients undergoing simultaneously FGM, CGM and self-monitoring blood glucose during hemodialysis and non-hemodialysis days. Their conclusions showed that the use of FGM may be clinically relevant in this population, but MARDs for TBR and TIR were ...
People with diabetes and end-stage renal failure on maintenance haemodialysis are highly vulnerable, with complex comorbidities, and are at high risk of adverse cardiovascular outcomes, the leading cause of mortality in this population.
HbA 1c level is the most common indicator for glycemic control in diabetic patients and represents a time-weighted mean plasma glucose level during the preceding 1 to 3 months. The life span of red blood cells is approximately 120 days.
